Leah Haworth

7.7k total citations · 4 hit papers
21 papers, 6.1k citations indexed

About

Leah Haworth is a scholar working on Obstetrics and Gynecology, Immunology and Oncology. According to data from OpenAlex, Leah Haworth has authored 21 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Obstetrics and Gynecology, 9 papers in Immunology and 8 papers in Oncology. Recurrent topics in Leah Haworth's work include Uterine Myomas and Treatments (9 papers), Immunotherapy and Immune Responses (7 papers) and T-cell and B-cell Immunology (5 papers). Leah Haworth is often cited by papers focused on Uterine Myomas and Treatments (9 papers), Immunotherapy and Immune Responses (7 papers) and T-cell and B-cell Immunology (5 papers). Leah Haworth collaborates with scholars based in United States, Australia and India. Leah Haworth's co-authors include Steven A. Rosenberg, Richard M. Sherry, Suzanne L. Topalian, James Chih‐Hsin Yang, Douglas J. Schwartzentruber, Patrick Hwu, Seth M. Steinberg, Helen X. Chen, Sharon Mavroukakis and Nicholas P. Restifo and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Leah Haworth

20 papers receiving 5.9k citations

Hit Papers

A Randomized Trial of Bevacizumab, an Anti–Vascular Endot... 2002 2026 2010 2018 2003 2003 2005 2002 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
    2003 2.1k citations James Chih‐Hsin Yang, Leah Haworth et al. New England Journal of Medicine profile →
  2. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
    2003 1.2k citations Giao Q. Phan, James Chih‐Hsin Yang et al. Proceedings of the National Academy of Sciences profile →
  3. Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4
    2005 771 citations Peter Attia, Giao Q. Phan et al. Journal of Clinical Oncology profile →
  4. Phase I Study of the Intravenous Administration of AttenuatedSalmonella typhimuriumto Patients With Metastatic Melanoma
    2002 565 citations John Toso, Vee J. Gill et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leah Haworth United States 12 3.2k 2.5k 2.0k 1.2k 795 21 6.1k
Thomas E. Darga United States 25 3.1k 1.0× 2.5k 1.0× 1.6k 0.8× 1.2k 1.0× 746 0.9× 34 5.4k
Ravi A. Madan United States 43 4.3k 1.3× 3.2k 1.3× 1.5k 0.8× 2.2k 1.9× 650 0.8× 286 6.7k
Sumit K. Subudhi United States 37 4.0k 1.3× 3.6k 1.4× 1.5k 0.8× 1.8k 1.5× 741 0.9× 108 7.3k
Josef Vormoor Germany 35 3.5k 1.1× 1.5k 0.6× 3.2k 1.7× 499 0.4× 1.2k 1.5× 117 7.8k
Neil H. Segal United States 43 5.8k 1.8× 2.8k 1.1× 1.7k 0.8× 2.2k 1.8× 1.0k 1.3× 149 8.6k
Junzo Hamanishi Japan 33 4.4k 1.4× 3.6k 1.4× 1.7k 0.9× 965 0.8× 873 1.1× 142 7.4k
Anna C. Ferrari United States 24 2.8k 0.9× 2.4k 0.9× 2.2k 1.1× 2.3k 1.9× 851 1.1× 56 5.9k
Robert B. Sims United States 16 3.0k 0.9× 2.8k 1.1× 1.3k 0.7× 2.1k 1.7× 631 0.8× 44 5.5k
Liufu Deng China 22 4.0k 1.2× 4.5k 1.8× 1.8k 0.9× 1.2k 1.0× 554 0.7× 34 7.3k
Daniela Bruni France 11 2.7k 0.9× 2.2k 0.9× 1.2k 0.6× 944 0.8× 716 0.9× 13 4.4k

Countries citing papers authored by Leah Haworth

Since Specialization
Citations

This map shows the geographic impact of Leah Haworth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leah Haworth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leah Haworth more than expected).

Fields of papers citing papers by Leah Haworth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leah Haworth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leah Haworth. The network helps show where Leah Haworth may publish in the future.

Co-authorship network of co-authors of Leah Haworth

This figure shows the co-authorship network connecting the top 25 collaborators of Leah Haworth. A scholar is included among the top collaborators of Leah Haworth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leah Haworth. Leah Haworth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mamik, Mamta M., et al.. (2020). Laparoscopic‐assisted myomectomy: Surgery center versus outpatient hospital. Journal of obstetrics and gynaecology research. 46(3). 490–498. 4 indexed citations
2.
Haworth, Leah, et al.. (2020). Laparoscopic-assisted myomectomy with uterine artery occlusion at a freestanding ambulatory surgery center: a case series. Gynecological Surgery. 17(1). 7–7. 3 indexed citations
3.
Haworth, Leah, et al.. (2019). Laparoscopic Hysterectomy Outcomes: Hospital vs Ambulatory Surgery Center. JSLS Journal of the Society of Laparoscopic & Robotic Surgeons. 23(1). e2018.00076–e2018.00076. 7 indexed citations
4.
Haworth, Leah, et al.. (2019). A value-based evaluation of minimally invasive hysterectomy approaches. Gynecological Surgery. 16(1). 3 indexed citations
5.
Haworth, Leah, et al.. (2018). Laparoscopic-Assisted Myomectomy with Bilateral Uterine Artery Occlusion/Ligation. Journal of Minimally Invasive Gynecology. 26(5). 856–864. 9 indexed citations
6.
Haworth, Leah, et al.. (2018). Myomectomy: Factors Influencing Patient Decision-Making and Satisfaction [10D]. Obstetrics and Gynecology. 131(1). 43S–44S.
7.
Haworth, Leah, et al.. (2017). A Value-Based Approach to Hysterectomy: Comparison of Minimally Invasive Hysterectomy Techniques. Journal of Minimally Invasive Gynecology. 24(7). S147–S148. 1 indexed citations
8.
Haworth, Leah, et al.. (2017). Comparison of Clinical Outcomes of Laparoscopic Hysterectomy in an Ambulatory Surgery Center Versus Outpatient Hospital Setting. Journal of Minimally Invasive Gynecology. 24(7). S171–S171. 2 indexed citations
9.
Maker, Ajay V., James Chih‐Hsin Yang, Richard M. Sherry, et al.. (2006). Intrapatient Dose Escalation of Anti–CTLA-4 Antibody in Patients With Metastatic Melanoma. Journal of Immunotherapy. 29(4). 455–463. 214 indexed citations
10.
Cowen, Edward W., Leah Haworth, Susan Booher, et al.. (2006). Skin Reactions in a Subset of Patients With Stage IV Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen 4 Monoclonal Antibody as a Single Agent. Archives of Dermatology. 142(2). 166–72. 90 indexed citations
11.
Gritz, Linda, Richard M. Sherry, Andrea Abati, et al.. (2006). Evaluation of Prime/Boost Regimens Using Recombinant Poxvirus/Tyrosinase Vaccines for the Treatment of Patients with Metastatic Melanoma. Clinical Cancer Research. 12(8). 2526–2537. 39 indexed citations
12.
Maker, Ajay V., Giao Q. Phan, Peter Attia, et al.. (2005). Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study. Annals of Surgical Oncology. 12(12). 1005–1016. 380 indexed citations
13.
Blansfield, Joseph, James Chih‐Hsin Yang, Marybeth S. Hughes, et al.. (2005). Cytotoxic T-Lymphocyte-Associated Antigen-4 Blockage Can Induce Autoimmune Hypophysitis in Patients With Metastatic Melanoma and Renal Cancer. Journal of Immunotherapy. 28(6). 593–598. 276 indexed citations
14.
Attia, Peter, Ajay V. Maker, Leah Haworth, Linda Rogers-Freezer, & Steven A. Rosenberg. (2005). Inability of a Fusion Protein of IL-2 and Diphtheria Toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to Eliminate Regulatory T Lymphocytes in Patients With Melanoma. Journal of Immunotherapy. 28(6). 582–592. 231 indexed citations
15.
Attia, Peter, Giao Q. Phan, Ajay V. Maker, et al.. (2005). Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4. Journal of Clinical Oncology. 23(25). 6043–6053. 771 indexed citations breakdown →
16.
Elaraj, Dina M., Donald E. White, Seth M. Steinberg, et al.. (2004). A Pilot Study of Antiangiogenic Therapy with Bevacizumab and Thalidomide in Patients with Metastatic Renal Cell Carcinoma. Journal of Immunotherapy. 27(4). 259–264. 37 indexed citations
17.
Phan, Giao Q., James Chih‐Hsin Yang, Richard M. Sherry, et al.. (2003). Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proceedings of the National Academy of Sciences. 100(14). 8372–8377. 1234 indexed citations breakdown →
18.
Yang, James Chih‐Hsin, Leah Haworth, Richard M. Sherry, et al.. (2003). A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer. New England Journal of Medicine. 349(5). 427–434. 2100 indexed citations breakdown →
19.
Rosenberg, Steven A., James C. Yang, Richard M. Sherry, et al.. (2003). Inability to Immunize Patients with Metastatic Melanoma Using Plasmid DNA Encoding the gp100 Melanoma-Melanocyte Antigen. Human Gene Therapy. 14(8). 709–714. 85 indexed citations
20.
Toso, John, Vee J. Gill, Patrick Hwu, et al.. (2002). Phase I Study of the Intravenous Administration of AttenuatedSalmonella typhimuriumto Patients With Metastatic Melanoma. Journal of Clinical Oncology. 20(1). 142–152. 565 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas E. Darga Breakdown of academic impact, for papers by Ravi A. Madan Breakdown of academic impact, for papers by Sumit K. Subudhi Breakdown of academic impact, for papers by Josef Vormoor Breakdown of academic impact, for papers by Neil H. Segal Breakdown of academic impact, for papers by Junzo Hamanishi Breakdown of academic impact, for papers by Anna C. Ferrari Breakdown of academic impact, for papers by Robert B. Sims Breakdown of academic impact, for papers by Liufu Deng Breakdown of academic impact, for papers by Daniela Bruni
Rankless by CCL
2026